Tumor perivascular cell-derived extracellular vesicles promote angiogenesis via the Gas6/Axl pathway. (1st January 2022)
- Record Type:
- Journal Article
- Title:
- Tumor perivascular cell-derived extracellular vesicles promote angiogenesis via the Gas6/Axl pathway. (1st January 2022)
- Main Title:
- Tumor perivascular cell-derived extracellular vesicles promote angiogenesis via the Gas6/Axl pathway
- Authors:
- Huang, Maohua
Liu, Mingqun
Huang, Dandan
Ma, Yanping
Ye, Geni
Wen, Qing
Li, Yong
Deng, Lijuan
Qi, Qi
Liu, Tongzheng
Liu, Xiangning
Chen, Minfeng
Ye, Wencai
Zhang, Dongmei - Abstract:
- Abstract: Aberrant angiogenesis is a hallmark of cancer and is critically associated with tumor progression. Perivascular cells are essential components of blood vessels, and the role of tumor perivascular cell-derived extracellular vesicles (TPC-EVs) in angiogenesis remains elusive. In the present study, using genetic mouse models and pharmacological inhibitors, we found that ablation of perivascular cells inhibited angiogenesis in allografted colorectal cancer tumors. Further studies demonstrated that TPC-EVs promoted the proliferation, migration, invasion, viability, and tube formation of HUVECs. They also facilitated vessel spouting in rat aortic rings and induced neovascularization in chick chorioallantoic membranes (CAMs). Silencing of Gas6 or blockade of the Axl pathway suppressed TPC-EV-induced angiogenesis in vitro and ex vivo . Moreover, inhibition of the Gas6/Axl signaling pathway impaired TPC-EV-mediated angiogenesis in vivo . Our findings present a deeper insight into the biological functions of TPCs and TPC-EVs in tumor angiogenesis and demonstrate that TPC-EV-derived Gas6 could be an attractive and innovative regulator of tumor angiogenesis. Highlights: Tumor perivascular cell-derived extracellular vesicles (TPC-EVs) promote tumor angiogenesis. TPC-EVs promote tumor angiogenesis by activating the Gas6/Axl signaling pathway in endothelial cells. The EV-Gas6/Axl pathway is a feasible target for antiangiogenic therapy in colorectal cancer.
- Is Part Of:
- Cancer letters. Volume 524(2022)
- Journal:
- Cancer letters
- Issue:
- Volume 524(2022)
- Issue Display:
- Volume 524, Issue 2022 (2022)
- Year:
- 2022
- Volume:
- 524
- Issue:
- 2022
- Issue Sort Value:
- 2022-0524-2022-0000
- Page Start:
- 131
- Page End:
- 143
- Publication Date:
- 2022-01-01
- Subjects:
- Perivascular cells -- Extracellular vesicles -- Colorectal cancer -- Angiogenesis
TPC-EVs tumor perivascular cell-derived extracellular vesicles -- CAMs chick chorioallantoic membranes -- TKIs tyrosine kinase inhibitors -- S1P sphingosine 1-phosphate -- HBVPs human brain vascular pericytes -- TPCs tumor perivascular cells -- EVs extracellular vesicles -- EPCs endothelial progenitor cells -- Tk thymidine kinase -- GCV ganciclovir -- MVD microvessel density
Cancer -- Periodicals
Neoplasms -- Periodicals
Cancer -- Périodiques
Electronic journals
616.994 - Journal URLs:
- http://www.sciencedirect.com/science/journal/03043835/ ↗
http://www.elsevier.com/journals ↗ - DOI:
- 10.1016/j.canlet.2021.10.023 ↗
- Languages:
- English
- ISSNs:
- 0304-3835
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 3046.485000
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 19699.xml